These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 28774842)
1. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842 [TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855 [TBL] [Abstract][Full Text] [Related]
3. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663 [TBL] [Abstract][Full Text] [Related]
4. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958 [TBL] [Abstract][Full Text] [Related]
5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809 [TBL] [Abstract][Full Text] [Related]
6. Transport Mechanisms of Butyrate Modified Nanoparticles: Insight into "Easy Entry, Hard Transcytosis" of Active Targeting System in Oral Administration. Wu L; Bai Y; Liu M; Li L; Shan W; Zhang Z; Huang Y Mol Pharm; 2018 Sep; 15(9):4273-4283. PubMed ID: 30102863 [TBL] [Abstract][Full Text] [Related]
7. A novel ligand conjugated nanoparticles for oral insulin delivery. Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690 [TBL] [Abstract][Full Text] [Related]
8. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway. Zheng Y; Wu J; Shan W; Wu L; Zhou R; Liu M; Cui Y; Zhou M; Zhang Z; Huang Y ACS Appl Mater Interfaces; 2018 Oct; 10(40):34039-34049. PubMed ID: 30207680 [TBL] [Abstract][Full Text] [Related]
10. The use of low molecular weight protamine to enhance oral absorption of exenatide. Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems. Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375 [TBL] [Abstract][Full Text] [Related]
12. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin. Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099 [TBL] [Abstract][Full Text] [Related]
13. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738 [TBL] [Abstract][Full Text] [Related]
14. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery. Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398 [TBL] [Abstract][Full Text] [Related]
15. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery. Zhang Y; Zhang L; Ban Q; Li J; Li CH; Guan YQ Nanomedicine; 2018 Feb; 14(2):353-364. PubMed ID: 29157980 [TBL] [Abstract][Full Text] [Related]
17. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292 [TBL] [Abstract][Full Text] [Related]
18. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
19. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
20. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration. Urimi D; Agrawal AK; Kushwah V; Jain S AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]